Dementia and Neurodegeneration — Imaging Patterns
Neurodegenerative disease leaves predictable imaging fingerprints — atrophy patterns on T1 MPRAGE (which lobe, which nucleus), signal abnormalities on T2 / SWI / DWI for specific diagnoses, and molecular biomarkers on PET (amyloid, tau, FDG, DaTscan). This page maps the patterns to the syndromes — AD, FTD, DLB, MSA, PSP, CBD, CJD, NPH — and the signs you should never miss.
🔹 Bottom Line: Dementia & Neurodegen MRI
- Alzheimer disease (AD): bilateral medial temporal + parietal atrophy; FDG parietotemporal hypometabolism + posterior cingulate; amyloid PET positive; tau PET positive in MTL → cortex.
- DLB: relatively preserved hippocampi; DAT-SPECT abnormal; FDG occipital hypometabolism + cingulate island sign; MIBG reduced.
- FTD (bvFTD): frontal + anterior temporal atrophy; FDG frontal hypometabolism; amyloid PET typically negative.
- PSP: midbrain atrophy (“hummingbird,” “morning glory” signs); MR Parkinsonism Index; FDG midbrain + frontal hypometabolism.
- MSA: cerebellar / brainstem atrophy (MSA-C: “hot cross bun” pons; MSA-P: putaminal atrophy + slit-like dorsolateral T2 hyperintensity).
- CBD: asymmetric frontoparietal atrophy contralateral to clinical signs.
- CJD: cortical ribbon DWI restriction + basal ganglia + pulvinar (variant) or pulvinar/cortical (sporadic).
- NPH: ventriculomegaly out of proportion to atrophy + DESH pattern + Evans index >0.3 + callosal angle <90°.
- CAA: lobar microbleeds + cortical superficial siderosis (Boston 2.0 criteria).
Alzheimer Disease (AD)
Structural MRI
- Medial temporal lobe atrophy: hippocampus + entorhinal cortex (Scheltens MTA score 0–4).
- Parietal atrophy: precuneus + posterior cingulate (Koedam visual score).
- Bilateral, symmetric, progressive.
- Spares sensorimotor cortex.
- Whole-brain atrophy + ventricular enlargement (Evans index rises).
Functional / Molecular Imaging
- FDG-PET: bilateral parietotemporal + posterior cingulate / precuneus hypometabolism. Spares sensorimotor + occipital.
- Amyloid PET: positive (loss of gray-white contrast).
- Tau PET: positive starting MTL (Braak I-II) → temporoparietal (III-IV) → diffuse cortical (V-VI).
AD Variants
- Logopenic PPA: left temporoparietal atrophy + amyloid-positive in most.
- Posterior cortical atrophy (PCA): bilateral parieto-occipital atrophy; often AD pathology.
- Frontal variant AD: mimics FTD; amyloid PET positive distinguishes.
Frontotemporal Dementia (FTD) Spectrum
Behavioral Variant FTD (bvFTD)
- Frontal + anterior temporal atrophy — bilateral but often asymmetric.
- Sparing of posterior cortex (early).
- FDG-PET: bilateral frontal hypometabolism.
- Amyloid PET: typically negative.
Semantic Variant PPA (svPPA / Semantic Dementia)
- Anterior temporal lobe atrophy — typically asymmetric (often left).
- “Knife-edge” temporal pole.
- FDG: anterior temporal hypometabolism.
Non-Fluent Variant PPA (nfvPPA)
- Left inferior frontal + insular atrophy.
- FDG: left inferior frontal hypometabolism.
FTD-MND (Motor Neuron Disease)
- FTD + ALS-like motor signs.
- C9orf72 hexanucleotide expansion in many cases.
Dementia with Lewy Bodies (DLB)
Structural MRI
- Relatively preserved hippocampi compared to AD.
- Generalized atrophy possible.
- No specific structural sign.
Molecular / Functional Imaging
- DAT-SPECT (DaTscan): abnormal — asymmetric putaminal uptake loss.
- I-123 MIBG cardiac scintigraphy: reduced cardiac uptake (sympathetic denervation).
- FDG-PET: occipital hypometabolism + “cingulate island sign” (preserved posterior cingulate relative to surrounding parietal hypometabolism) — distinguishes from AD.
- Polysomnography: RBD (REM sleep behavior disorder) is a core feature.
Progressive Supranuclear Palsy (PSP)
Structural MRI Signs
- Hummingbird sign: midbrain atrophy with preserved pons → midbrain looks like a hummingbird beak on sagittal T1.
- Morning glory sign: concave (atrophic) midbrain tegmentum on axial.
- Mickey Mouse sign: atrophic midbrain with prominent cerebral peduncles.
- MR Parkinsonism Index (MRPI): (P/M × MCP/SCP) — high values support PSP.
- Midbrain : pons ratio <0.52 supports PSP.
- Cerebral peduncle and superior cerebellar peduncle atrophy.
Functional Imaging
- FDG-PET: bilateral midbrain + frontal hypometabolism.
- DAT-SPECT: abnormal (but doesn’t distinguish from PD).
Multiple System Atrophy (MSA)
MSA-C (Cerebellar Predominant)
- Cerebellar atrophy.
- Middle cerebellar peduncle atrophy.
- Pontine atrophy + “hot cross bun” sign: cruciform T2 hyperintensity in pons (degenerated pontocerebellar fibers).
MSA-P (Parkinsonian Predominant)
- Putaminal atrophy + low T2 signal (iron).
- Slit-like dorsolateral putaminal T2 hyperintensity.
- “Putaminal rim sign” (T2 hyperintense rim on 1.5T; less specific on 3T due to normal rim).
Common to Both
- Autonomic dysfunction.
- DAT-SPECT abnormal.
- MIBG: variable.
Corticobasal Degeneration (CBD)
Imaging
- Asymmetric frontoparietal atrophy contralateral to the clinically affected side.
- FDG-PET: asymmetric frontoparietal + basal ganglia hypometabolism.
- DAT-SPECT: abnormal (often asymmetric).
Huntington Disease (HD)
Imaging
- Caudate + putaminal atrophy: caudate “flattening” of normally convex curve into lateral ventricle → “boxcar” ventricles.
- Frontal atrophy.
- FDG-PET: caudate + putaminal hypometabolism (early, before structural atrophy).
Creutzfeldt-Jakob Disease (CJD)
Sporadic CJD (sCJD)
- Cortical ribbon DWI restriction: highly suggestive of sCJD in the appropriate rapidly progressive dementia context — but NOT pathognomonic. Mimics include status epilepticus / postictal change, severe hypoglycemia, hypoxic-ischemic injury, HSV encephalitis, hyperammonemia, and MELAS stroke-like episodes. Always correlate with EEG, CSF (14-3-3, RT-QuIC), and clinical trajectory.
- Basal ganglia (caudate + putamen) DWI restriction.
- FLAIR hyperintensity in same regions.
- Asymmetric findings common.
- Spares thalamus typically.
Variant CJD (vCJD)
- Pulvinar sign: bilateral posterior thalamus (pulvinar) FLAIR/T2 hyperintensity — highly characteristic.
- “Hockey stick sign”: pulvinar + dorsomedial thalamus.
- Cortical involvement less prominent than sporadic.
Genetic CJD
- Variable imaging features.
- PRNP sequencing confirms (see Genetics).
Normal Pressure Hydrocephalus (NPH)
Imaging Criteria
- Ventriculomegaly out of proportion to atrophy: Evans index >0.3 (frontal horn width / max biparietal diameter).
- DESH pattern (Disproportionately Enlarged Subarachnoid space Hydrocephalus): tight high convexity sulci + enlarged Sylvian fissures + enlarged ventricles.
- Callosal angle <90° on coronal at the level of posterior commissure.
- Transependymal CSF flow: smooth periventricular T2/FLAIR halo.
- Aqueduct CSF flow void: prominent on T2 (high-velocity flow).
Imaging Mimics
- Age-related ventriculomegaly (proportional to atrophy) — NOT NPH.
- Other communicating hydrocephalus (post-SAH, post-meningitis).
Cerebral Amyloid Angiopathy (CAA)
Imaging
- Lobar microbleeds (SWI): cortical/subcortical, multiple, elderly, sparing deep gray.
- Cortical superficial siderosis: linear hemosiderin deposition along cortex (SWI).
- Lobar ICH: posterior > anterior; classic location for CAA.
- White matter changes: leukoaraiosis (especially posterior).
- Boston 2.0 criteria for CAA diagnosis (multidimensional imaging-based).
- Distinguishes from hypertensive vasculopathy (deep microbleeds).
Small Vessel Disease (SVD) / Subcortical Vascular Dementia
Imaging Features
- White matter hyperintensities (WMH): confluent periventricular T2/FLAIR.
- Lacunes: small (<15 mm) deep infarcts in lenticulostriate / pontine / thalamoperforator territory.
- Microbleeds: deep (basal ganglia, thalamus, pons) on SWI.
- Perivascular spaces dilated: especially in basal ganglia (état criblé).
- Fazekas score for WMH severity (0–3 periventricular + 0–3 deep).
CADASIL
- Anterior temporal pole T2 hyperintensity: characteristic.
- External capsule + corpus callosum (genu) T2 hyperintensities.
- Deep gray microbleeds + lacunes.
- NOTCH3 mutation (see Genetics).
Adult Leukodystrophies (Briefly)
- ALSP (CSF1R): frontal-predominant white matter + thin corpus callosum + adult onset.
- X-ALD (adrenomyeloneuropathy): adult-onset spastic paraparesis + neuropathy + adrenal insufficiency; MRI may be normal in AMN; cerebral form shows posterior white matter T2 hyperintensity + enhancement.
- CTX: cerebellar + cerebral white matter + dentate signal change.
- See Leukodystrophy / Genetics pages for full coverage.
🔹 Clinical Relevance: Imaging in the Dementia Workup
- Reversible causes first: NPH (DESH + callosal angle), B12 / thyroid (lab), tumor (post-contrast MRI), SDH (CT/MRI), CAA-related inflammation (steroid-responsive).
- AD diagnosis: MTL atrophy on MRI + confirmed amyloid pathology (amyloid PET or CSF biomarkers) + supportive tau evidence (tau PET, CSF p-tau181). Tau PET supports but doesn’t establish AD alone — interpret in the broader biomarker context.
- Lecanemab / donanemab eligibility: requires confirmation of amyloid pathology before treatment, by amyloid PET OR CSF biomarkers (Aβ42/40 ratio, p-tau181). Validated plasma assays emerging in triage workflows.
- AD vs FTD: pattern of atrophy + FDG-PET (parieto-temp vs frontal) + amyloid PET (positive vs negative).
- AD vs DLB: DAT-SPECT (abnormal in DLB) + cingulate island sign on FDG + RBD + parkinsonism + visual hallucinations.
- PSP vs PD: hummingbird sign + early postural instability + vertical gaze palsy.
- MSA-C vs SCA: hot cross bun + putaminal atrophy + autonomic dysfunction → MSA.
- Rapidly progressive dementia: think CJD (DWI ribbon), autoimmune encephalitis, paraneoplastic, infectious — escalate to LP + CSF biomarkers + MRI + targeted antibody panels.
- Lobar microbleeds + cortical superficial siderosis: CAA — anticoagulation risk discussion.
Pitfalls and Pearls
- Hippocampal atrophy is not specific to AD: also FTD, vascular dementia, CJD, normal aging.
- Cingulate island sign on FDG-PET: highly specific for DLB.
- Hummingbird sign + axial morning glory: PSP.
- Hot cross bun pons: MSA-C.
- Slit-like dorsolateral putaminal T2 hyperintensity: MSA-P (more reliable than putaminal rim on 3T).
- Cortical ribbon DWI restriction: highly suggestive of sCJD in a rapidly progressive dementia context — not pathognomonic. Mimics: status / postictal, hypoglycemia, HIE, HSV encephalitis, hyperammonemia, MELAS. Correlate with EEG + 14-3-3 + RT-QuIC.
- Bilateral pulvinar T2 hyperintensity: variant CJD; also Fabry, mitochondrial.
- Hockey stick sign: variant CJD pulvinar + dorsomedial thalamus.
- NPH vs atrophy: DESH pattern + callosal angle <90° supports NPH; proportional sulcal + ventricular enlargement = atrophy.
- Amyloid PET positivity rises with age: ~30% of cognitively normal 70-year-olds positive; clinical context essential.
- Tau PET correlates with cognitive decline better than amyloid does — tau is the “executor.”
- Boston 2.0 criteria for CAA: incorporate lobar microbleeds + cortical superficial siderosis + lobar ICH + age.
- CAA-related inflammation (CAA-ri): subacute encephalopathy + leukoencephalopathy + microbleeds + responds to steroids — don’t miss it.
- “Knife-edge” temporal pole: semantic dementia.
- Boxcar ventricles + caudate flattening: HD.
- Anti-IgLON5 disease: hypothalamic + brainstem MRI changes + REM sleep behavior disorder + dysphagia — emerging autoimmune/tauopathy syndrome.
References
- McKeith IG, Boeve BF, Dickson DW, et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88-100.
- Höglinger GU, Respondek G, Stamelou M, et al. Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria. Mov Disord. 2017;32(6):853-864.
- Wenning GK, Stankovic I, Vignatelli L, et al. The Movement Disorder Society criteria for the diagnosis of multiple system atrophy. Mov Disord. 2022;37(6):1131-1148.
- Zerr I, Kallenberg K, Summers DM, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(10):2659-2668.
- Charidimou A, Boulouis G, Frosch MP, et al. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022;21(8):714-725.
- Relkin N, Marmarou A, Klinge P, et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005;57(3 Suppl):S4-S16.
- Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 2018;14(4):535-562.